Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chenglin Zhao

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Biomed Research International|November 12, 2015
Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD ScoreDong Fang, Da Ren, Chenglin Zhao, et al.
Discover Oncology|April 18, 2026
PARP4 drives tumor progression by promoting glioma cell proliferation and invasion as a potential therapeutic targetBingqi Lu, Zhou Jing, Fangyuan Wang, et al.
Discover Oncology|October 27, 2025
Comprehensive analysis of mitochondria-associated genes in glioblastoma via single-cell and bulk RNA sequencingFangyuan Wang, Ao Huo, Minghe Li, et al.
Discover Oncology|June 16, 2026
SOAT1 expression associates with prognosis, immune environment and biochemical indicators in gliomaWeihua Hu, Wulong Liang, Xuyang Guo, et al.
Annals of Surgical Oncology|July 29, 2016
Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese PopulationDong Fang, Chenglin Zhao, Da Ren, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Biomed Research International|November 12, 2015
Prevalence and Risk Factors of Prostate Cancer in Chinese Men with PSA 4-10 ng/mL Who Underwent TRUS-Guided Prostate Biopsy: The Utilization of PAMD ScoreDong Fang, Da Ren, Chenglin Zhao, et al.
Discover Oncology|April 18, 2026
PARP4 drives tumor progression by promoting glioma cell proliferation and invasion as a potential therapeutic targetBingqi Lu, Zhou Jing, Fangyuan Wang, et al.
Discover Oncology|October 27, 2025
Comprehensive analysis of mitochondria-associated genes in glioblastoma via single-cell and bulk RNA sequencingFangyuan Wang, Ao Huo, Minghe Li, et al.
Discover Oncology|June 16, 2026
SOAT1 expression associates with prognosis, immune environment and biochemical indicators in gliomaWeihua Hu, Wulong Liang, Xuyang Guo, et al.
Annals of Surgical Oncology|July 29, 2016
Could Magnetic Resonance Imaging Help to Identify the Presence of Prostate Cancer Before Initial Biopsy? The Development of Nomogram Predicting the Outcomes of Prostate Biopsy in the Chinese PopulationDong Fang, Chenglin Zhao, Da Ren, et al.
Pageof 4